sellWeak cluster of 210b5-1 plan
Kate Haviland sold $216k of BPMC
CHIEF EXECUTIVE OFFICER at Blueprint Medicines Corp. 2,498 shares at an average of $86.65, traded Apr 1, 2025, filed Apr 3, 2025.
Warning score
25Value
$216k
2,498 shares
Holdings after
165,929
-1% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +25RoleCEO
- +12Trade size$216k at market
- 0Share of holdings soldSold 1.5% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001415889-25-009959, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 1, 2025 | SOpen-market sale Common Stock10b5-1 | -600 | $85.47 | $51k | 167,827 | Apr 3, 2025 |
| Apr 1, 2025 | SOpen-market sale Common Stock10b5-1 | -598 | $86.14 | $52k | 167,229 | Apr 3, 2025 |
| Apr 1, 2025 | SOpen-market sale Common Stock10b5-1 | -1,200 | $87.34 | $105k | 166,029 | Apr 3, 2025 |
| Apr 1, 2025 | SOpen-market sale Common Stock10b5-1 | -100 | $88.59 | $8,859 | 165,929 | Apr 3, 2025 |
Related signals
Other insiders at Blueprint Medicines Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 34Weak | Blueprint Medicines Corp | Percy H. Carter CHIEF SCIENTIFIC OFFICER | $135k 1,051 shares | -2% | |
| 39Weak | Blueprint Medicines Corp | Christina Rossi CHIEF OPERATING OFFICER | $150k 1,172 shares | -2% | |
| 38Weak | Blueprint Medicines Corp | Percy H. Carter CHIEF SCIENTIFIC OFFICER | $340k 2,659 shares | -5% | |
| 13Weak | Blueprint Medicines Corp | Jeffrey W. Albers director | $506k 5,000 shares | -3% | |
| 28Weak | Blueprint Medicines Corp | Christina Rossi CHIEF OPERATING OFFICER | $229k 2,274 shares | -3% | |
| 7Weak | Blueprint Medicines Corp | Ariel Hurley PRINCIPAL ACCOUNTING OFFICER | $284k 2,752 shares | -14% | |
| 21Weak | Blueprint Medicines Corp | Christina Rossi CHIEF OPERATING OFFICER | $231k 2,274 shares | -3% | |
| 27Weak | Blueprint Medicines Corp | Christina Rossi CHIEF OPERATING OFFICER | $216k 2,274 shares | -3% | |
| 48Moderate | Blueprint Medicines Corp | Jeffrey W. Albers director | $512k 5,766 shares | -4% | |
| 15Weak | Blueprint Medicines Corp | Jeffrey W. Albers director | $659k 7,500 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.